Clinical and genetic characteristics of Korean autosomal dominant polycystic kidney disease patients

키워드

참고문헌 (76)

1. Chapman AB, "Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference", Kidney Int, 88, pp.17~27 (2015)
2. Churchill DN, "Prognosis of adult onset polycystic kidney disease re-evaluated", Kidney Int, 26, pp.190~193 (1984)
3. Chapman AB, "Approaches to testing new treatments in autosomal dominant polycystic kidney disease : insights from the CRISP and HALT-PKD studies", Clin J Am Soc Nephrol, 3, pp.1197~1204 (2008)
4. Gabow PA, "Autosomal dominant polycystic kidney disease", N Engl J Med, 329, pp.332~342 (1993)
5. Dalgaard OZ, "Bilateral polycystic disease of the kidneys; a follow-up of two hundred and eighty-four patients and their families", Acta Med Scand Suppl, 328, pp.1~255 (1957)
6. Suwabe T, "Epidemiology of autosomal dominant polycystic kidney disease in olmsted county", Clin J Am Soc Nephrol, 15, pp.69~79 (2020)
7. Willey CJ, "Prevalence of autosomal dominant polycystic kidney disease in the European Union", Nephrol Dial Transplant, 32, pp.1356~1363 (2017)
8. "Frequent disease statistics of outpatients in 2019" (2019)[URL]
9. Kalatharan V, "Diagnostic accuracy of administrative codes for autosomal dominant polycystic kidney disease in clinic patients with cystic kidney disease", Clin Kidney J, 14, pp.612~616 (2020)
10. Spithoven EM, "Renal replacement therapy for autosomal dominant polycystic kidney disease(ADPKD)in Europe : prevalence and survival : an analysis of data from the ERA-EDTA Registry", Nephrol Dial Transplant, 29(Suppl 4), pp.iv15~iv25 (2014)
11. "Current renal replacement therapy in Korea: Insan Memorial Dialysis Registry, 2018" (2019)[URL]
12. Harris PC, "Polycystic kidney disease", Annu Rev Med, 60, pp.321~337 (2009)
13. Porath B, "Mutations in GANAB, encoding the glucosidase iiα subunit, cause autosomal-dominant polycystic kidney and liver disease", Am J Hum Genet, 98, pp.1193~1207 (2016)
14. Cornec-Le Gall E, "Monoallelic mutations to DNAJB11 cause atypical autosomal-dominant polycystic kidney disease", Am J Hum Genet, 102, pp.832~844 (2018)
15. Sandford R, "Comparative analysis of the polycystic kidney disease 1(PKD1)gene reveals an integral membrane glycoprotein with multiple evolutionary conserved domains", Hum Mol Genet, 6, pp.1483~1489 (1997)
16. Hughes J, "The polycystic kidney disease 1(PKD1)gene encodes a novel protein with multiple cell recognition domains", Nat Genet, 10, pp.151~160 (1995)
17. Su Q, "Structure of the human PKD1-PKD2 complex", Science, 361, pp.eaat9819~ (2018)
18. Yang Y, "Structural studies of the C-terminal tail of polycystin-2(PC2)reveal insights into the mechanisms used for the functional regulation of PC2", J Physiol, 594, pp.4141~4149 (2016)
19. Torres VE, "Mechanisms of disease : autosomal dominant and recessive polycystic kidney diseases", Nat Clin Pract Nephrol, 2, pp.40~55 (2006)
20. Massella L, "Prevalence of hypertension in children with early-stage ADPKD", Clin J Am Soc Nephrol, 13, pp.874~883 (2018)
21. Chebib FT, "Autosomal dominant polycystic kidney disease : core curriculum 2016", Am J Kidney Dis, 67, pp.792~810 (2016)
22. Oh Kook-Hwan, "The KNOW-CKD Study: What we have learned about chronic kidney diseases", Kidney Research and Clinical Practice, 39(2), pp.121~135 (2020), 대한신장학회[DOI]
23. Kim H, "Baseline characteristics of the autosomal-dominant polycystic kidney disease sub-cohort of the KoreaN cohort study for outcomes in patients with chronic kidney disease", Nephrology (Carlton), 24, pp.422~429 (2019)
24. Lee KB, "Clinical progression and complications of autosomal dominant polycystic kidney disease in Korea", Korean J Nephrol, 18, pp.707~713 (1999)
25. 황영환, "말기 신부전으로 진행하는 한국인 상염색체우성 다낭신 환자의 임상적 특징", Kidney Research and Clinical Practice, 20(2), pp.212~220 (2001), 대한신장학회
26. Hogan MC, "Liver involvement in early autosomal-dominant polycystic kidney disease", Clin Gastroenterol Hepatol, 13, pp.155~164 (2015)
27. Chebib FT, "Effect of genotype on the severity and volume progression of polycystic liver disease in autosomal dominant polycystic kidney disease", Nephrol Dial Transplant, 31, pp.952~960 (2016)
28. Sherstha R, "Postmenopausal estrogen therapy selectively stimulates hepatic enlargement in women with autosomal dominant polycystic kidney disease", Hepatology, 26, pp.1282~1286 (1997)
29. Irazabal MV, "Extended follow-up of unruptured intracranial aneurysms detected by presymptomatic screening in patients with autosomal dominant polycystic kidney disease", Clin J Am Soc Nephrol, 6, pp.1274~1285 (2011)
30. Xu HW, "Screening for intracranial aneurysm in 355 patients with autosomal-dominant polycystic kidney disease", Stroke, 42, pp.204~206 (2011)
31. Pei Y, "Unified criteria for ultrasonographic diagnosis of ADPKD", J Am Soc Nephrol, 20, pp.205~212 (2009)
32. Pei Y, "Imaging-based diagnosis of autosomal dominant polycystic kidney disease", J Am Soc Nephrol, 26, pp.746~753 (2015)
33. Symmons O, "How segmental duplications shape our genome : recent evolution of ABCC6and PKD1 Mendelian disease genes", Mol Biol Evol, 25, pp.2601~2613 (2008)
34. Bogdanova N, "Homologues to the first gene for autosomal dominant polycystic kidney disease are pseudogenes", Genomics, 74, pp.333~341 (2001)
35. Rossetti S, "Comprehensive molecular diagnostics in autosomal dominant polycystic kidney disease", J Am Soc Nephrol, 18, pp.2143~2160 (2007)
36. Cornec-Le Gall E, "Type of PKD1 mutation influences renal outcome in ADPKD", J Am Soc Nephrol, 24, pp.1006~1013 (2013)
37. Carrera P, "Deciphering variability of PKD1 and PKD2 in an Italian cohort of 643patients with autosomal dominant polycystic kidney disease(ADPKD)", Sci Rep, 6, pp.30850~ (2016)
38. Hwang YH, "Refining genotype-phenotype correlation in autosomal dominant polycystic kidney disease", J Am Soc Nephrol, 27, pp.1861~1868 (2016)
39. Kim H, "Genetic characteristics of Korean patients with autosomal dominant polycystic kidney disease by targeted exome sequencing", Sci Rep, 9, pp.16952~ (2019)
40. Iliuta IA, "Polycystic kidney disease without an apparent family history", J Am Soc Nephrol, 28, pp.2768~2776 (2017)
41. Hildebrandt F, "Ciliopathies", N Engl J Med, 364, pp.1533~1543 (2011)
42. Park HC, "Genetic identification of inherited cystic kidney diseases for implementing precision medicine : a study protocol for a 3-year prospective multicenter cohort study", BMC Nephrol, 22, pp.2~ (2021)
43. Bullich G, "A kidney-disease gene panel allows a comprehensive genetic diagnosis of cystic and glomerular inherited kidney diseases", Kidney Int, 94, pp.363~371 (2018)
44. Dicks E, "Incident renal events and risk factors in autosomal dominant polycystic kidney disease : a population and family-based cohort followed for 22 years", Clin J Am Soc Nephrol, 1, pp.710~717 (2006)
45. Hateboer N, "Comparison of phenotypes of polycystic kidney disease types 1 and 2. European PKD1-PKD2 Study Group", Lancet, 353, pp.103~107 (1999)
46. Heyer CM, "Predicted mutation strength of nontruncating PKD1 mutations aids genotype-phenotype correlations in autosomal dominant polycystic kidney disease", J Am Soc Nephrol, 27, pp.2872~2884 (2016)
47. Kataoka H, "Prediction of renal prognosis in patients with autosomal dominant polycystic kidney disease using PKD1", PKD2 mutations, 2020, pp.9, 146~
48. Chapman AB, "Kidney volume and functional outcomes in autosomal dominant polycystic kidney disease", Clin J Am Soc Nephrol, 7, pp.479~486 (2012)
49. Irazabal MV, "Imaging classification of autosomal dominant polycystic kidney disease : a simple model for selecting patients for clinical trials", J Am Soc Nephrol, 26, pp.160~172 (2015)
50. Yu ASL, "Baseline total kidney volume and the rate of kidney growth are associated with chronic kidney disease progression in autosomal dominant polycystic kidney disease", Kidney Int, 93, pp.691~699 (2018)
51. Cornec-Le Gall E, "The PROPKD score : a new algorithm to predict renal survival in autosomal dominant polycystic kidney disease", J Am Soc Nephrol, 27, pp.942~951 (2016)
52. Gansevoort RT, "Recommendations for the use of tolvaptan in autosomal dominant polycystic kidney disease : a position statement on behalf of the ERA-EDTA Working Groups on Inherited Kidney Disorders and European Renal Best Practice", Nephrol Dial Transplant, 31, pp.337~348 (2016)
53. Ryu H, "RAPID-ADPKD(Retrospective epidemiological study of Asia-Pacific patients with rapId Disease progression of Autosomal Dominant Polycystic Kidney Disease) : study protocol for a multinational, retrospective cohort study", BMJ Open, 10, pp.e034103~ (2020)
54. Ecder T, "Hypertension in autosomal-dominant polycystic kidney disease : early occurrence and unique aspects", J Am Soc Nephrol, 12, pp.194~200 (2001)
55. Schrier RW, "Blood pressure in early autosomal dominant polycystic kidney disease", N Engl J Med, 371, pp.2255~2266 (2014)
56. Chebib FT, "Recent advances in the management of autosomal dominant polycystic kidney disease", Clin J Am Soc Nephrol, 13, pp.1765~1776 (2018)
57. Torres VE, "A case for water in the treatment of polycystic kidney disease", Clin J Am Soc Nephrol, 4, pp.1140~1150 (2009)
58. Torres VE, "Tolvaptan in patients with autosomal dominant polycystic kidney disease", N Engl J Med, 367, pp.2407~2418 (2012)
59. Torres VE, "Tolvaptan in later-stage autosomal dominant polycystic kidney disease", N Engl J Med, 377, pp.1930~1942 (2017)
60. Torres VE, "Multicenter study of long-term safety of tolvaptan in later-stage autosomal dominant polycystic kidney disease", Clin J Am Soc Nephrol, 16, pp.48~58 (2020)
61. Sallee M, "Cyst infections in patients with autosomal dominant polycystic kidney disease", Clin J Am Soc Nephrol, 4, pp.1183~1189 (2009)
62. Kim H, "Clinical experience with white blood cell-PET", CT in autosomal dominant polycystic kidney disease patients with suspected cyst infection : a prospective case series, 2018, pp.23, 661~668
63. Kim H, "Clinical correlates of mass effect in autosomal dominant polycystic kidney disease", PLoS One, 10, pp.e0144526~ (2015)
64. Ryu H, "Total kidney and liver volume is a major risk factor for malnutrition in ambulatory patients with autosomal dominant polycystic kidney disease", BMC Nephrol, 18, pp.22~ (2017)
65. de Mutsert R, "Excess mortality due to interaction between protein-energy wasting, inflammation and cardiovascular disease in chronic dialysis patients", Nephrol Dial Transplant, 23, pp.2957~2964 (2008)
66. 진동찬, "Analysis of mortality risk from Korean hemodialysis registry data 2017", Kidney Research and Clinical Practice, 38(2), pp.169~175 (2019), 대한신장학회[DOI]
67. 김세중, "Time-varying effects of body mass index on mortality among hemodialysis patients: Results from a nationwide Korean registry", Kidney Research and Clinical Practice, 38(1), pp.90~99 (2019), 대한신장학회[DOI]
68. 김좌경, "Impact of sarcopenia on long-term mortality and cardiovascular events in patients undergoing hemodialysis", The Korean Journal of Internal Medicine, 34(3), pp.599~607 (2019), 대한내과학회[DOI]
69. Ryu H, "Bioelectrical impedance analysis as a nutritional assessment tool in autosomal dominant polycystic kidney disease", PLoS One, 14, pp.e0214912~ (2019)
70. Sun Moon Kim, "Nutritional management in patients with chronic kidney disease", The Korean Journal of Internal Medicine, 35(6), pp.1279~1290 (2020), 대한내과학회[DOI]
71. Ejaz AA, "Hyperuricemia in kidney disease : a major risk factor for cardiovascular events, vascular calcification, and renal damage", Semin Nephrol, 40, pp.574~585 (2020)
72. Jung Hwan Park, "Renal effects of uric acid: hyperuricemia and hypouricemia", The Korean Journal of Internal Medicine, 35(6), pp.1291~1304 (2020), 대한내과학회[DOI]
73. Ran-hui Cha, "Physicians’ perceptions of asymptomatic hyperuricemia in patients with chronic kidney disease: A questionnaire survey", Kidney Research and Clinical Practice, 38(3), pp.373~381 (2019), 대한신장학회[DOI]
74. Helal I, "Serum uric acid, kidney volume and progression in autosomal-dominant polycystic kidney disease", Nephrol Dial Transplant, 28, pp.380~385 (2013)
75. Han M, "Hyperuricemia and deterioration of renal function in autosomal dominant polycystic kidney disease", BMC Nephrol, 15, pp.63~ (2014)
76. Testa F, "ADPKD current management and ongoing trials", J Nephrol, 33, pp.223~237 (2020)

관련 논문AI추천